Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01168856 · ClinicalTrials.gov registry record
An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens
A clinical trial, sponsored by Hoffmann-La Roche.
- Terminated
- Registry status
- 734
- Enrollment target
NCT01168856: Clinical Trial study, sponsored by Hoffmann-La Roche.
NCT01168856 is a clinical trial that was terminated before completion, run by Hoffmann-La Roche. The registered enrollment target is 734 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01168856 was terminated before completion, sponsored by Hoffmann-La Roche.
- TERMINATED
- Registry status
- 734 participants
- Enrollment target
Study Summary
This observational long-term follow-up study will assess the persistence of direct acting antiviral (DAA) resistant mutations and the durability of sustained virological response in patients with chronic hepatitis C who have participated in a Roche DAA treatment protocol. Up to 5 scheduled monitoring visits for blood sampling during an observational period of up to 36 months.
Primary Outcome
Serum HCV RNA concentration was determined using the Roche COBAS TaqMan HCV Test (Detection limit = 15 International Units per milliliter \[IU/mL\]).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 734 participants |
| Start Date | 2010-09 |
| Est. Completion | 2015-04 |
Why NCT01168856 stopped before completion
NCT01168856 is an observational study that tracks outcomes without assigning an intervention. The registered 734 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01168856 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01168856 about?
NCT01168856 is a clinical study titled "An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens". This observational long-term follow-up study will assess the persistence of direct acting antiviral (DAA) resistant mutations and the durability of sustained virological response in patients with chronic hepatitis C who have participated in a Roche DAA treatment protocol. Up to 5 scheduled monitorin...
What is the current status of trial NCT01168856?
This trial is currently terminated. The enrollment target is 734 participants. The study started on 2010-09. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01168856?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06216301 · 734 participants · Phase 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- NCT07231419 · 734 participants · Phase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
- NCT05947851 · 735 participants · Phase 3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
- NCT05999084 · 735 participants
Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia